Company: CORT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001628280-25-019942
Chunk: 6

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 6
---
 will serve until the annual meeting of stockholders in 2026 or until their successors are duly elected and qualified. There are no family relationships among any of our directors or executive officers.

The name, age at April 17, 2025 and principal occupation of each person nominated for election to the Board, all of whom currently serve as our directors, are set forth below:

| Name                           |     | Age |     | Occupation                                               |
| Joseph K. Belanoff, M.D.       |     |  67 |     | Chief Executive Officer and President                    |
| James N. Wilson(1)             |     |  81 |     | Chairman of the Board                                    |
| Gregg Alton(2)(3)              |     |  59 |     | Former Chief Patient Officer of Gilead Sciences, Inc.    |
| G. Leonard Baker, Jr.(1)(2)    |     |  82 |     | Venture Capitalist                                       |
| Gillian M. Cannon, Ph.D.(1)(3) |     |  61 |     | Former Head of Commercial Innovation at Roivant Sciences |
| David L. Mahoney(2)(3)         |     |  70 |     | Private Investor                                         |
| Joshua M. Murray(3)            |     |  41 |     | Chief Financial Officer and Head of Strategy of Orca Bio |
| Kimberly Park(1)               |     |  61 |     | Former Global Vice President of Merck & Co.              |
| Daniel N. Swisher, Jr.(2)      |     |  62 |     | Chief Executive Officer of NodThera, Inc.                |

| (1) |     | Member of Corporate Governance and Nominating Committee |
| (2) |     | Member of Compensation Committee                        |
| (3) |     | Member of Audit Committee                               |

Our director nominees have acted throughout their careers with integrity, honesty and adherence to high ethical standards. They have also demonstrated business acumen and sound judgment we believe will benefit Corcept.

Joseph K. Belanoff, M.D. is a co-founder of our Company and has served as a member of our Board and our Chief Executive Officer since Corcept’s inception in 1999, and as our President since 2014. Dr. Belanoff is an Adjunct Professor of Psychiatry at Stanford University (School of Medicine), where he has held positions in the Department of Psychiatry and Behavioral